ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

XE vs TMO // PIOTROSKI F-SCORE QUALITY

X-Energy Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: XE 6 — TMO 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XE VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC XE TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 41.00% 41.00% 0.00 TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 38.50% 9.30% +29.20 XE /roic <GO>
EV/EBITDA & P/E Valuation 18.8x 30.4x -11.60 XE /valuation <GO>
Free Cash Flow Yield 2.21% 2.40% -0.19 TMO /fcf-yield <GO>
Operating Margin 13.90% 17.40% -3.50 TMO /operating-margins <GO>
Net Profit Margin 10.90% 15.10% -4.20 TMO /net-margins <GO>
Revenue Growth (YoY) 4.40% 3.90% +0.50 XE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity 8.69 4.50 +4.19 XE /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 8/9 8/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew 7.10% 6.70% +0.40 TMO /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 35.6 59.1 -23.54 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.05 0.94 +0.11 XE /macro-sensitivity <GO>
Forward P/E Multiple 30.5x 36.3x -5.80 XE /forward-pe <GO>
Enterprise Scale & Market Cap $4.75B $262.22B -$257.46B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR XE REV TMO REV XE GROSS % TMO GROSS % XE FCF TMO FCF
FY 2025 $0 $44.56B — 44.0% $0 $6.29B
FY 2024 — $42.88B — 44.0% — $7.27B
FY 2023 — $42.86B — 44.0% — $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XE // BETA 1.05
TMO // BETA 0.94